{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:40:05Z","timestamp":1760611205985,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":4157,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1053\/rmed.2001.1239","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T10:55:08Z","timestamp":1032432908000},"page":"193-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Plasminogen activator inhibitor-1 (PAI-1) polymorphisms in patients with obstructive sleep apnoea"],"prefix":"10.1053","volume":"96","author":[{"given":"A.","family":"BARCEL\u00d3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"LLOMPART","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"BARB\u00c9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"MORL\u00c1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"VILA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.N.","family":"AGUST\u00cd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/rmed.2001.1239_RF1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0140-6736(90)91799-G","article-title":"Association of sleep apnoea with myocardial infarction in men","volume":"336","author":"Hung","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/rmed.2001.1239_RF2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","author":"Peppard","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/rmed.2001.1239_RF3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/ajrccm.163.1.2001008","article-title":"Sleep-disordered breathing and cardiovascular disease","volume":"163","author":"Shahar","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2001.1239_RF4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1164\/ajrccm.163.1.ed1400d","article-title":"The Link between sleep apnoea and cardiovascular disease","volume":"163","author":"Hedner","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/rmed.2001.1239_RF5","first-page":"823","article-title":"Speculations on the interaction between vascular disease and obstructive sleep apnoea","author":"Hedner","year":"1994"},{"key":"10.1053\/rmed.2001.1239_RF6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","article-title":"Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris","volume":"332","author":"Thompson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/rmed.2001.1239_RF7","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/0140-6736(93)92062-X","article-title":"Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study","volume":"342","author":"Meade","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/rmed.2001.1239_RF8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(87)93050-9","article-title":"Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction","volume":"2","author":"Hamsten","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/rmed.2001.1239_RF9","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","article-title":"The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene 65respond differently to interleukin 1 in HepG2 cells","volume":"268","author":"Dawson","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1053\/rmed.2001.1239_RF10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1055\/s-0038-1649833","article-title":"The 4G\/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma activity but not with risk of myocardial infarction in the ECTIM study","volume":"74","author":"Ye","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1053\/rmed.2001.1239_RF11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1055\/s-0037-1615408","article-title":"The 4G\/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis","volume":"80","author":"Iacovello","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1053\/rmed.2001.1239_RF12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/sleep\/18.3.188","article-title":"Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnoea patients","volume":"18","author":"Rangemark","year":"1995","journal-title":"Sleep"},{"key":"10.1053\/rmed.2001.1239_RF13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/sleep\/11.5.430","article-title":"Identifying sleep from self-reports","volume":"11","author":"Kapuniai","year":"1988","journal-title":"Sleep"},{"key":"10.1053\/rmed.2001.1239_RF14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0038-1655968","article-title":"PAI-1 Concentrations in first-degree relatives of patients with non-insulin-dependent diabetes: metabolic and genetic associations","volume":"77","author":"Mansfield","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1053\/rmed.2001.1239_RF15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0002-9343(99)80395-7","article-title":"The relationship between systemic hypertension and obstructive sleep apnoea: facts and theory","volume":"98","author":"Fletcher","year":"1995","journal-title":"Am J Med"},{"key":"10.1053\/rmed.2001.1239_RF16","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/sleep\/16.suppl_8.S15","article-title":"Possible atherogenic effects of hypoxia during obstructive sleep apnoea","volume":"16","author":"Dean","year":"1993","journal-title":"Sleep"},{"key":"10.1053\/rmed.2001.1239_RF17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1034\/j.1399-3003.2000.16d13.x","article-title":"Abnormal lipid peroxidation in patients with sleep apnoea","volume":"16","author":"Barcelo","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1053\/rmed.2001.1239_RF18","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allele-specific increase in basal transcription of the olasminogen-activator inhibitor 1 gene is associated with myocardial infarction","volume":"92","author":"Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/rmed.2001.1239_RF19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/01.CIR.95.1.59","article-title":"Arterial and venous thrombosis is not associatedwith the 4G\/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men","volume":"95","author":"Ridker","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/rmed.2001.1239_RF20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1055\/s-0038-1656042","article-title":"Plasminogen activator inhibitor-1 (PAI-1) 4G\/5G promoter polymorphism and levels in subjects with cerebrovascular disease","volume":"77","author":"Catto","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1053\/rmed.2001.1239_RF21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI307","article-title":"Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expresion by hypoxia promotes pulmonary vascular fibrin deposition","volume":"102","author":"Pinsky","year":"1998","journal-title":"J Clin Invest"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611101912399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611101912399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:59:05Z","timestamp":1760608745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611101912399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0954611101912399"],"URL":"https:\/\/doi.org\/10.1053\/rmed.2001.1239","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasminogen activator inhibitor-1 (PAI-1) polymorphisms in patients with obstructive sleep apnoea","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/rmed.2001.1239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}